MYLAN GT 8 MYLAN GT 8 (Galantamine hydrobromide extended release 8 mg)
Pill imprint MYLAN GT 8 MYLAN GT 8 has been identified as Galantamine hydrobromide extended release 8 mg.
Galantamine is used in the treatment of alzheimer's disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Galantamine 8 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN GT 8 MYLAN GT 8
- Strength:
- 8 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-8105
- Inactive Ingredients:
- silicon dioxide
FD&C Red No. 40
gelatin
magnesium stearate
povidone
sodium lauryl sulfate
titanium dioxide
Note: Inactive ingredients may vary.
More about galantamine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 8 Reviews – Add your own review/rating
- Drug class: cholinesterase inhibitors
Consumer resources
- Galantamine
- Galantamine extended-release capsules
- Galantamine solution
- Galantamine (Advanced Reading)
Other brands: Razadyne, Razadyne ER
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
